Streetbeat News

Acquisitions Mergers

QDEL

Bloomberg reported that QuidelOrtho is considering the sale of its transfusion medicine unit. The company is exploring options that could include a sale or spinoff of the business. The transfusion medicine unit is part of QuidelOrtho's broader diagnostics business, and the potential sale is part of a strategic review to streamline operations and focus on core areas.

Portfolio Pulse from Charles Gross

November 15, 2023 | 10:43 pm

CF

CF Industries has announced the expiration of the HSR Act waiting period for its acquisition of the Waggaman ammonia production facility. This step is a significant milestone in the regulatory process, indicating that the acquisition can proceed without further antitrust scrutiny from U.S. regulators. The completion of this phase may positively influence investor sentiment as it clears a major hurdle in the acquisition process.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:44 pm

NVTA

Aranscia has acquired select assets of the YouScript Personalized Medication Management Platform from Invitae Corporation in an all-cash transaction. The financial terms of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:39 pm

NVTA

Aranscia has acquired YouScript, a precision dosing analytics platform, from Invitae Corporation (NVTA). This acquisition could potentially enhance Aranscia's capabilities in providing personalized medication management.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:37 pm

ESTC

Elastic, the company behind Elasticsearch, has announced its intention to acquire Opster, although the financial terms of the deal have not been disclosed. This acquisition could potentially enhance Elastic's product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:36 pm

VII

7GC & Co. Holdings has announced that the SEC has declared its Form S-4 registration statement effective, in connection with its proposed business combination with Banzai. This is a key step towards completing the merger, which will result in Banzai becoming a publicly listed company.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:34 pm

CEAD

CEA Industries Inc. (NASDAQ:CEAD) reported a significant decrease in revenue for Q3 2023, with $0.9 million compared to $5.1 million in Q3 2022. Net bookings and backlog also declined, while operating expenses were cut by 58%. The net loss improved slightly, and the company remains debt-free with $13.3 million in cash. The CEO mentioned that the Board is considering strategic alternatives, including a sale, merger, or other transaction. CEAD's stock was up 3.02% at $0.51 per share.

Portfolio Pulse from Joana Scopel

November 15, 2023 | 9:33 pm

MPU

Mega Matrix Corp has entered into a non-binding letter of intent with Yuder Pte, which involves an exchange for 1.5 million shares of Mega Matrix's common stock.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:28 pm

RGP

Resources Connection, Inc. has completed the acquisition of CloudGo Pte Ltd., a Singapore-based company with ServiceNow Elite Partner status and operations in Singapore, Australia, and India. CloudGo, founded in 2016, has nearly 80 employees and is expected to achieve significant revenue growth in 2023.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 9:17 pm

CYBN

Cybin Inc. (NYSE:CYBN), a clinical-stage biotech company, reported its Q2 financial results, showing a cash balance of $13.25 million and increased R&D expenses. The company has access to over $101 million, including proceeds from share issuances and an ATM equity program. Cybin has made progress in its psychedelics programs, with positive interim data for CYB003 in MDD, acquisition of Small Pharma Inc., and additional patent acquisitions. Upcoming milestones include Phase 2 data readouts, FDA submissions, and initiation of Phase 3 trials.

Portfolio Pulse from Lara Goldstein

November 15, 2023 | 8:38 pm